LTRN - Lantern Pharma - Stock Forecast

Healthcare - Sector

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Lantern Pharma's activity chart (see below) currently has 12 price targets and 12 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by from RODMAN & RENSHAW on 10-Aug-2023. First documented stock forecast 28-Jul-2020.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 08-Oct-2021

$11

$7.14 (184.97%)

$11

3 years 1 months 2 days ago
(10-Aug-2023)

0/9 (0%)

$6 (120.00%)

Buy Since 28-Jul-2020

$24

$22.88 (2042.86%)

6 years 1 months 15 days ago
(28-Jul-2020)

0/1 (0%)

$11.77 (96.24%)

Show more analysts

Which analyst most recently updated their price target on LTRN (Lantern Pharma)?

Which analyst has the most public recommendations on LTRN (Lantern Pharma)?

has 0 price targets and 0 ratings on LTRN

Which analyst is the currently most bullish on LTRN (Lantern Pharma)?

Kyle Bauser with the highest potential upside of $22.88

Which analyst is the currently most reserved on LTRN (Lantern Pharma)?

Michael King with the lowest potential downside of $7.14